Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Mar-Apr;25(2):179-180.
doi: 10.4103/aian.aian_847_21. Epub 2022 Feb 9.

Idiopathic Intracranial Hypertension- The Eyes and Beyond

Sucharita Ray  1 , Aastha Takkar  1 , Vivek Lal  1
Affiliations
Editorial

Idiopathic Intracranial Hypertension- The Eyes and Beyond

Sucharita Ray et al. Ann Indian Acad Neurol. 2022 Mar-Apr.
No abstract available

PubMed Disclaimer

References

    1. Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81:1159–65. - PubMed
    1. Prabhat N, Chandel S, Takkar DA, Ahuja C, Singh R, Kathirvel S, et al. Sensitivity and specificity of neuroimaging signs in patients with idiopathic intracranial hypertension. Neuroradiol J. 2021;34:421–7. - PMC - PubMed
    1. Cello KE, Keltner JL, Johnson CA, Wall M NORDIC Idiopathic Intracranial Hypertension Study Group. Factors affecting visual field outcomes in the idiopathic intracranial hypertension treatment trial. J Neuroophthalmol. 2016;36:6–12. - PubMed
    1. Takkar A, Goyal MK, Bansal R, Lal V. Clinical and neuro-ophthalmologic predictors of visual outcome in idiopathic intracranial hypertension. Neuroophthalmol. 2018;42:201–8. - PMC - PubMed
    1. Wall M, Johnson CA, Cello KE, Zamba KD, McDermott MP, Keltner JL, et al. Visual field outcomes for the idiopathic intracranial hypertension treatment trial (IIHTT) Invest Ophthalmol Vis Sci. 2016;57:805–12. - PMC - PubMed

Publication types